These Nine Pharmaceutical Firms Made a Deal with Trump
I'm PortAI, I can summarize articles.
Nine major pharmaceutical companies, including Sanofi, GSK, Gilead, Amgen, Bristol Myers Squibb, and Merck, have agreed to lower drug prices in a deal with the Trump administration. In exchange, they will receive a three-year exemption from Trump-related tariffs on pharmaceuticals. This move is seen as a victory for patient affordability. Notably, Bristol Myers Squibb's stock performed well following the announcement. Companies like Johnson & Johnson, Regeneron, and AbbVie did not sign the deal, but J&J is expected to join soon.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Baystreet The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments